Hammersmith Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2006

  1. Transient silencing of Plasmodium falciparum bifunctional glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase

    FEBS Journal, Vol. 273, Núm. 7, pp. 1537-1546

2002

  1. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections

    Blood, Vol. 100, Núm. 3, pp. 1026-1030

1999

  1. Three major G6PD-deficient polymorphic variants identified among the Mauritian population

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 849-854

1998

  1. Amino acid substitutions at the dimer interface of human glucose-6-phosphate dehydrogenase that increase thermostability and reduce the stabilising effect of NADP

    European Journal of Biochemistry, Vol. 251, Núm. 1-2, pp. 382-388

1996

  1. Unproductive folding of the human G6PD-deficient variant A-

    FASEB Journal, Vol. 10, Núm. 1, pp. 153-158

1995

  1. A new glucose-6-phosphate dehydrogenase variant, G6PD Orissa (44 Ala→Gly), is the major polymorphic variant in tribal populations in India

    American Journal of Human Genetics, Vol. 57, Núm. 6, pp. 1335-1341

1992

  1. Both mutations in G6PD A - are necessary to produce the G6PD deficient phenotype

    Human Molecular Genetics, Vol. 1, Núm. 3, pp. 171-174